Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.

Actions

• 2019-01-04Referred to the Committee on the Budget, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2019-01-04Referred to the Committee on the Budget, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2019-01-04Introduced in House
• 2019-01-04Introduced in House

CRS Summary

As of 2019-01-04 (00)

Cosponsors (20)

• Mark Pocan (D-WI)
• Ro Khanna (D-CA)
• JAMES MCGOVERN (D-MA)
• Alexandria Ocasio-Cortez (D-NY)
• JERROLD NADLER (D-NY)
• BARBARA LEE (D-CA)
• NYDIA VELAZQUEZ (D-NY)
• Chellie Pingree (D-ME)
• Brenda Lawrence (D-MI)
• Jamie Raskin (D-MD)
• Adriano Espaillat (D-NY)
• JANICE SCHAKOWSKY (D-IL)
• Yvette Clarke (D-NY)
• Raúl Grijalva (D-AZ)
• JOSE SERRANO (D-NY)
• Jimmy Gomez (D-CA)
• GRACE NAPOLITANO (D-CA)
• Bonnie Watson Coleman (D-NJ)
• Mark Takano (D-CA)
• Tulsi Gabbard (D-HI)

Subjects

• Appropriations
• Budget deficits and national debt
• Budget process